Background and purpose: In asthma, histamine contributes to bronchoconstriction, vasodilatation and oedema, and is associated with the late phase response. The current study investigates possible inflammatory effects of histamine acting on nuclear factor kB (NF-kB)-dependent transcription and cytokine release. Experimental approach: Using BEAS-2B bronchial epithelial cells, NF-kB-dependent transcription and both release and mRNA expression of IL-6 and IL-8 were examined by reporter assay, ELISA and quantitative RT-PCR. Histamine receptors were detected using qualitative RT-PCR and function examined using selective agonists and antagonists. Key results: Addition of histamine to TNFa-stimulated BEAS-2B cells maximally potentiated NF-kB-dependent transcription 1.8 fold, whereas IL-6 and IL-8 protein release were enhanced 7.3-and 2.7-fold respectively. These responses were, in part, NF-kBdependent and were associated with 2.6-and 1.7-fold enhancements of IL-6 and IL-8 mRNA expression. The H 1 receptor antagonist, mepyramine, caused a rightward shift in the concentration-response curves of TNFa-induced NF-kB-dependent transcription (pA 2 ¼ 9.91) and release of IL-6 (pA 2 ¼ 8.78) and IL-8 (pA 2 ¼ 8.99). Antagonists of histamine H 2 , H 3 and H 4 receptors were without effect. Similarly, H 3 and H 4 receptor agonists did not affect TNFa-induced NF-kB-dependent transcription, or IL-6 and IL-8 release at concentrations below 10 mM. The anti-inflammatory glucocorticoid, dexamethasone, inhibited the histamine enhanced NF-kB-dependent transcription and IL-6 and IL-8 release. Conclusions and implications: Potentiation of NF-kB-dependent transcription and inflammatory cytokine release by histamine predominantly involves receptors of the H 1 receptor subtype. These data support an anti-inflammatory role for H 1 receptor antagonists by preventing the transcription and release of pro-inflammatory cytokines.